Dendritic cell therapy for Type 1 diabetes suppression

Immunotherapy ◽  
2012 ◽  
Vol 4 (10) ◽  
pp. 1063-1074 ◽  
Author(s):  
Nick Giannoukakis ◽  
Massimo Trucco
Keyword(s):  
Type 1 Diabetes ◽  
Dendritic Cell ◽  
Cell Therapy ◽  
Dendritic Cell Therapy

scholarly journals It's Time to Bring Dendritic Cell Therapy to Type 1 Diabetes

Diabetes ◽  
2013 ◽  
Vol 63 (1) ◽  
pp. 20-30 ◽  
Author(s):  
R. J. Creusot ◽  
N. Giannoukakis ◽  
M. Trucco ◽  
M. J. Clare-Salzler ◽  
C. G. Fathman
Keyword(s):  
Type 1 Diabetes ◽  
Dendritic Cell ◽  
Cell Therapy ◽  
Dendritic Cell Therapy

Cell therapy for type-1 diabetes

2009 ◽  
Vol 3 (6) ◽  
pp. 511-518
Author(s):  
I. B. Sokolova
Keyword(s):  
Type 1 Diabetes ◽  
Cell Therapy

PS17 - 86. Clinical grade dendritic cell vaccine to treat type 1 diabetes retain stable tolerogenic properties

2011 ◽  
Vol 9 (3) ◽  
pp. 150-150
Author(s):  
Tatjana Nikolic ◽  
Fleur S. Kleijwegt ◽  
Josefine Teeler ◽  
Sandra Laban ◽  
Antoinette M. Joosten ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Clinical Grade

scholarly journals The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes

Cells ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1589
Author(s):  
Ryota Inoue ◽  
Kuniyuki Nishiyama ◽  
Jinghe Li ◽  
Daisuke Miyashita ◽  
Masato Ono ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Islet Cells ◽  
Autologous Transplantation ◽  
Insulin Injection ◽  
Islet Cell Transplantation ◽  
The Impact

Stem cell therapy using islet-like insulin-producing cells derived from human pluripotent stem cells has the potential to allow patients with type 1 diabetes to withdraw from insulin therapy. However, several issues exist regarding the use of stem cell therapy to treat type 1 diabetes. In this review, we will focus on the following topics: (1) autoimmune responses during the autologous transplantation of stem cell-derived islet cells, (2) a comparison of stem cell therapy with insulin injection therapy, (3) the impact of the islet microenvironment on stem cell-derived islet cells, and (4) the cost-effectiveness of stem cell-derived islet cell transplantation. Based on these various viewpoints, we will discuss what is required to perform stem cell therapy for patients with type 1 diabetes.

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

2009 ◽  
Vol 35 (2) ◽  
pp. 85-93 ◽  
Author(s):  
L. Vija ◽  
D. Farge ◽  
J.-F. Gautier ◽  
P. Vexiau ◽  
C. Dumitrache ◽  
...  
Keyword(s):  
Stem Cells ◽  
Type 1 Diabetes ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy

scholarly journals Invariant Natural Killer T-Cell Control of Type 1 Diabetes: A Dendritic Cell Genetic Decision of a Silver Bullet or Russian Roulette

Diabetes ◽  
2009 ◽  
Vol 59 (2) ◽  
pp. 423-432 ◽  
Author(s):  
J. P. Driver ◽  
F. Scheuplein ◽  
Y.-G. Chen ◽  
A. E. Grier ◽  
S. B. Wilson ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
T Cell ◽  
Dendritic Cell ◽  
Natural Killer ◽  
Cell Control ◽  
Natural Killer T Cell ◽  
Invariant Natural Killer ◽  
Silver Bullet ◽  
Killer T Cell
Sign in / Sign up

Export Citation Format

Share Document